Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anatole Besarab

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of Vascular Surgery|March 6, 2002
Recommended standards for reports dealing with arteriovenous hemodialysis accessesAnton N Sidawy, Richard Gray, Anatole Besarab, et al.
BMC Nephrology|September 1, 2012
An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patientsAnatole Besarab, Steven N Zeig, Edouard R Martin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 6, 2016
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy StudyRobert Provenzano, Anatole Besarab, Steven Wright, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2012
Academic interventional nephrology: a model for training, research, and patient carePrabir Roy-Chaudhury, Alexander Yevzlin, Joseph V Bonventre, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2021
Roxadustat for anemia in patients with end-stage renal disease incident to dialysisRobert Provenzano, Evgeny Shutov, Liubov Eremeeva, et al.
The New England Journal of Medicine|January 25, 2013
Peginesatide in patients with anemia undergoing hemodialysisSteven Fishbane, Brigitte Schiller, Francesco Locatelli, et al.
Journal of Vascular Surgery|November 19, 2008
The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis accessAnton N Sidawy, Lawrence M Spergel, Anatole Besarab, et al.
Journal of the American Society of Nephrology : JASN|October 24, 2015
Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis PatientsAnatole Besarab, Elena Chernyavskaya, Igor Motylev, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2010
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trialFernando Carrera, Charmaine E Lok, Angel de Francisco, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 9, 2009
Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortalityNeil C Boudville, Ognjenka Djurdjev, Iain C Macdougall, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Vascular Surgery|March 6, 2002
Recommended standards for reports dealing with arteriovenous hemodialysis accessesAnton N Sidawy, Richard Gray, Anatole Besarab, et al.
BMC Nephrology|September 1, 2012
An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patientsAnatole Besarab, Steven N Zeig, Edouard R Martin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 6, 2016
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy StudyRobert Provenzano, Anatole Besarab, Steven Wright, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2012
Academic interventional nephrology: a model for training, research, and patient carePrabir Roy-Chaudhury, Alexander Yevzlin, Joseph V Bonventre, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2021
Roxadustat for anemia in patients with end-stage renal disease incident to dialysisRobert Provenzano, Evgeny Shutov, Liubov Eremeeva, et al.
The New England Journal of Medicine|January 25, 2013
Peginesatide in patients with anemia undergoing hemodialysisSteven Fishbane, Brigitte Schiller, Francesco Locatelli, et al.
Journal of Vascular Surgery|November 19, 2008
The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis accessAnton N Sidawy, Lawrence M Spergel, Anatole Besarab, et al.
Journal of the American Society of Nephrology : JASN|October 24, 2015
Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis PatientsAnatole Besarab, Elena Chernyavskaya, Igor Motylev, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2010
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trialFernando Carrera, Charmaine E Lok, Angel de Francisco, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 9, 2009
Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortalityNeil C Boudville, Ognjenka Djurdjev, Iain C Macdougall, et al.
Pageof 9